BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11057874)

  • 1. In vivo stimulation of vascular plasminogen activator inhibitor-1 production by very low-density lipoprotein involves transcription factor binding to a VLDL-responsive element.
    Dichtl W; Ares MP; Stollenwerk M; Giachelli CM; Scatena M; Hamsten A; Eriksson P; Nilsson J
    Thromb Haemost; 2000 Oct; 84(4):706-11. PubMed ID: 11057874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of upstream stimulatory factor 1 to the E-box regulates the 4G/5G polymorphism-dependent plasminogen activator inhibitor 1 expression in mast cells.
    Ma Z; Jhun B; Jung SY; Oh CK
    J Allergy Clin Immunol; 2008 Apr; 121(4):1006-1012.e2. PubMed ID: 18234320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
    Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
    Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells.
    Kutz SM; Providence KM; Higgins PJ
    Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.
    Tipping PG; Davenport P; Gallicchio M; Filonzi EL; Apostolopoulos J; Wojta J
    Am J Pathol; 1993 Sep; 143(3):875-85. PubMed ID: 8362983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins.
    Kaneko T; Wada H; Wakita Y; Minamikawa K; Nakase T; Mori Y; Deguchi K; Shirakawa S
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):385-92. PubMed ID: 8075310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor regulates E box-dependent plasminogen activator inhibitor type 1 gene expression in HepG2 liver cells.
    Imagawa S; Fujii S; Dong J; Furumoto T; Kaneko T; Zaman T; Satoh Y; Tsutsui H; Sobel BE
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2407-13. PubMed ID: 16902162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 plasminogen activator inhibitor is not an acute phase reactant in rats. Lack of IL-6- and hepatocyte-dependent synthesis.
    Podor TJ; Hirsh J; Gelehrter TD; Zeheb R; Torry D; Guigoz Y; Sierra F; Gauldie J
    J Immunol; 1993 Jan; 150(1):225-35. PubMed ID: 7678029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a stable prostacyclin analogue beraprost sodium on VEGF and PAI-1 gene expression in vascular smooth muscle cells.
    Atsuta H; Uchiyama T; Kanai H; Iso T; Tanaka T; Suga T; Maeno T; Arai M; Nagai R; Kurabayashi M
    Int J Cardiol; 2009 Mar; 132(3):411-8. PubMed ID: 18471910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rac-1 promotes pulmonary artery smooth muscle cell proliferation by upregulation of plasminogen activator inhibitor-1: role of NFkappaB-dependent hypoxia-inducible factor-1alpha transcription.
    Diebold I; Djordjevic T; Hess J; Görlach A
    Thromb Haemost; 2008 Dec; 100(6):1021-8. PubMed ID: 19132225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of AP-1 on expression of plasminogen activator inhibitor-1 in human vascular endothelial cells].
    Li XD; Zu SY; Wang W; Zhu GJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):307-11. PubMed ID: 12905745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes.
    Allen RR; Qi L; Higgins PJ
    J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation.
    Ma Z; Paek D; Oh CK
    Clin Exp Allergy; 2009 Aug; 39(8):1136-44. PubMed ID: 19438580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of PAI-1 expression by tumor necrosis factor alpha in endothelial cells is mediated by its responsive element located in the 4G/5G site.
    Swiatkowska M; Szemraj J; Cierniewski CS
    FEBS J; 2005 Nov; 272(22):5821-31. PubMed ID: 16279946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the interaction of a complex of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 with rat liver cells.
    Kuiper J; Otter M; Voorschuur AH; van Zonneveld AJ; Rijken DC; van Berkel TJ
    Thromb Haemost; 1995 Nov; 74(5):1298-304. PubMed ID: 8607113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia.
    Eriksson P; Nilsson L; Karpe F; Hamsten A
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):20-6. PubMed ID: 9445251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential and opposing regulation of PAI-1 promoter activity by estrogen receptor alpha and estrogen receptor beta in endothelial cells.
    Smith LH; Coats SR; Qin H; Petrie MS; Covington JW; Su M; Eren M; Vaughan DE
    Circ Res; 2004 Aug; 95(3):269-75. PubMed ID: 15217907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB-dependent pathways in cultured human umbilical vein endothelial cells.
    Hamaguchi E; Takamura T; Shimizu A; Nagai Y
    J Pharmacol Exp Ther; 2003 Dec; 307(3):987-94. PubMed ID: 14534369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of oxidized and glycated low-density lipoproteins on transcription and secretion of plasminogen activator inhibitor-1 in vascular endothelial cells.
    Ma GM; Halayko AJ; Stelmack GL; Zhu F; Zhao R; Hillier CT; Shen GX
    Cardiovasc Pathol; 2006; 15(1):3-10. PubMed ID: 16414450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1.
    Chen Y; Budd RC; Kelm RJ; Sobel BE; Schneider DJ
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1777-83. PubMed ID: 16709941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.